Clearance of Lynkuet provides a new alternative to hormone-based treatment for hot flashes and sets up a market battle with ...
Lynkuet is the first FDA-approved therapy that blocks both the neurokinin 1 and neurokinin 3 receptors to treat hot flashes.
The U.S. Food and Drug Administration has approved Bayer's drug to ease hot flashes in menopausal women, the German company ...
The US Food and Drug Administration has approved another once-a-day pill that works without hormones to treat moderate to severe hot flashes in menopausal women, drugmaker Bayer said Friday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback